Switch to
More onapp

How to use scorecard? Learn more

Parnax Lab Ltd

PARNAXLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹201 cr, stock is ranked 2,477
High RiskStock is 4.21x as volatile as Nifty
174.155.30 (-2.95%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹201 cr, stock is ranked 2,477
High RiskStock is 4.21x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
17.04
PB RatioPB Ratio
2.81
Dividend YieldDiv. Yield
Sector PESector PE
51.76
Sector PBSector PB
6.59
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Parnax Lab is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations

Financial TrendFinancial statements 

202120222023202490.27163.36168.38189.53-0.378.238.629.61
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 14, 2024

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Change in Management | Download

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Change in Management | Download

Result 
Announced OnNov 14, 2024

PARNAX LAB LTD. - 506128 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

PARNAX LAB LTD. - 506128 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

Board Meeting 
Announced OnNov 14, 2024

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

See all events